Serum peroxiredoxin-4, a biomarker of oxidative stress, associates with new-onset chronic kidney disease: A population-based cohort study

Authors: Geertsema, Sem, Geertsema, Paul, Kieneker, Lyanne M., Abdulle, Amaal E., la Bastide-van Gemert, Sacha, Bakker, Stephan J.L., Dullaart, Robin P.F., Dijkstra, Gerard, Gansevoort, Ron T., Faber, Klaas Nico, van Goor, Harry, Bourgonje, Arno R.

Source: In Redox Biology November 2024 77

The NRF2/Keap1 pathway as a therapeutic target in inflammatory bowel disease

Authors: Geertsema, Sem, Bourgonje, Arno R., Fagundes, Raphael R., Gacesa, Ranko, Weersma, Rinse K., van Goor, Harry, Mann, Giovanni E., Dijkstra, Gerard, Faber, Klaas N.

Source: In Trends in Molecular Medicine October 2023 29(10):830-842

Letter: disentangling the role of redox‐active compounds in the development of inflammatory bowel diseases – moving towards causal associations

Authors: Geertsema, Sem, van Goor, Harry, Dijkstra, Gerard, Faber, Klaas Nico, Bourgonje, Arno R.

Source: Alimentary pharmacology & therapeutics. 57(9):1046-1047

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100184353358.0x000001&indx=1&recIds=ETOCvdc_100184353358.0x000001

Unsuitability of the Oxidation-Reduction Potential Measurement for the Quantification of Fecal Redox Status in Inflammatory Bowel Disease.

Authors: Geertsema, Sem, Jansen, Bernadien H., van Goor, Harry, Dijkstra, Gerard, Faber, Klaas Nico, Bourgonje, Arno R.

Source: Biomedicines; Dec2023, Vol. 11 Issue 12, p3107, 11p

Subject Terms: INFLAMMATORY bowel diseases, OXIDATION-reduction potential, OXIDATION-reduction reaction, OXIDATIVE stress, MEASURING instruments

Recurrent Cholecystitis Due to Gallstone Obstruction of a Lumen-Apposing Metal Stent

Authors: Geertsema, Sem, Meinds, Rob J., Venneman, Niels G.

Source: Clinical gastroenterology and hepatology. 20(10):A28-A28

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100170426838.0x000001&indx=1&recIds=ETOCvdc_100170426838.0x000001

Sa1788 SYSTEMIC FREE THIOLS ASSOCIATE WITH CLINICAL AND BIOCHEMICAL DISEASE ACTIVITY IN INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE DIAGNOSTIC VALIDATION STUDY

Authors: Geertsema, Sem, Holstein, Hannah J., Bulthuis, Marian, Faber, Klaas Nico, Van Goor, Harry, Dijkstra, Gerard, Bourgonje, Arno R.

Source: In Gastroenterology 18-21 May 2024 166(5) Supplement:S

Sa1787 SYSTEMIC REDOX STATUS ASSOCIATES WITH DISEASE ACTIVITY AND CLINICAL PHENOTYPES IN INFLAMMATORY BOWEL DISEASE

Authors: Geertsema, Sem, Bourgonje, Arno R., Gacesa, Ranko, Fagundes, Raphael R., Spekhorst, Lieke M., Hu, Shixian, Kannan, Arun K., Ruane, Darren, de Jong, Sofie, Jansen, Dianne, Bulthuis, Marian, Reinders-Luinge, Marjan, Weersma, Rinse K., Van Goor, Harry, Dijkstra, Gerard, Faber, Klaas Nico

Source: In Gastroenterology 18-21 May 2024 166(5) Supplement:S

Evaluating Serum Free Thiols in Inflammatory Bowel Disease: Contribution of Albumin to Extracellular Free Thiol Status.

Authors: Bourgonje, Arno R, Geertsema, Sem, Holstein, Hannah J, Bulthuis, Marian L C, Dijkstra, Gerard, Faber, Klaas Nico, Goor, Harry van

Source: Inflammatory Bowel Diseases; Aug2024, Vol. 30 Issue 8, p1439-1440, 2p

Interleukin-18 Inhibition in Inflammatory Bowel Disease: A Delicate Balance.

Authors: Geertsema, Sem, Fagundes, Raphael R, Otten, Antonius T, Dijkstra, Gerard, Faber, Klaas Nico, Bourgonje, Arno R

Source: Inflammatory Bowel Diseases; Apr2024, Vol. 30 Issue 4, p693-694, 2p

Assessment of Fecal Glycosylated Mucins as Novel Biomarkers in Inflammatory Bowel Diseases.

Authors: Geertsema, Sem, Otten, Antonius T, Bouwknegt, Dianne G, Visschedijk, Marijn C, Bourgonje, Arno R

Source: Inflammatory Bowel Diseases; Mar2023, Vol. 29 Issue 3, pe10-e11, 2p